About R2M Pharma
R2M Pharma is a Healthcare company based in San Francisco (United States) founded in 2017 by Julio Medina. It offers target validation and compound optimization services for biotech drug development programs. It operates on a B2B model. The company has 1 employees. Its chief executive is Julio Medina. R2M Pharma offers products and services including Target Validation Services, Compound Optimization, DMPK Services, and Patent Strategy. Its focus areas include Life Sciences, Medicinal Chemistry, Therapeutics Optimization and DMPK and Patents. Its legal entity is R2M. Its competitors include Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH and 5 more; 7 of its 10 listed competitors have raised funding.
Company details
R2M Pharma specializes in accelerating drug discovery by providing expert services such as target validation, compound optimization, DMPK, and patent strategy to start-up biotech companies. They operate as a professional resource for firms lacking internal expertise, collaborating efficiently on small molecule development. Based in South San Francisco, USA, they have worked with clients like Tenaya Therapeutics to enhance drug programs.
- Headquarters San Francisco, United States
- Employees 1
- Founders Julio Medina
- SectorsHealthcare
- Website r2mpharma.com
- Social LinkedIn
- Legal Name R2m
- Employee Count1
Products & Services of R2M Pharma
R2M Pharma offers a comprehensive portfolio of products and services, including Target Validation Services, Compound Optimization, DMPK Services, and Patent Strategy.
Supports biotech firms in validating drug targets for development programs
Optimizes compounds to improve efficacy in small molecule drug creation
Handles drug metabolism and pharmacokinetic analysis for safety
Assists with patent development and strategy for biotech innovations
People of R2M Pharma
3 people are tracked at R2M Pharma (2 in leadership, 1 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Julio Medina | Founder, CEO | Leadership |
Edmond Mok | Interim CFO | Leadership |
Judy Szeto | Principal Scientist | Team |
Complete people profiles for R2M Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of R2M Pharma
R2M Pharma has 10 listed competitors in our database, 7 of them funded. They include Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evotec.com | 1993 | Hamburg, Germany | $25M | 252 | Drug discovery and development services are provided to biopharma sector. | |
| crownbio.com | 2006 | Santa Clara, United States | $85.87M | 18 | Cancer and CVMD drugs are developed using PDX models. | |
| alloytx.com | 2017 | Lexington, United States | $157M | – | Drug discovery services are provided for therapeutic development. | |
| domainex.co.uk | 2001 | Cambridge, United Kingdom | $4.97M | 93 | Drug discovery CRO company for epigenetic research and inflammatory diseases | |
| nih.gov | 1887 | United States | – | – | Drug discovery services are provided to the biopharma sector. | |
| vivabiotech.com | 2006 | Shanghai, China | – | – | Drug discovery and development research services are provided. | |
| catsci.com | 2010 | Cardiff, United Kingdom | $5.89M | 63 | Drug discovery services are provided to pharmaceutical clients worldwide. | |
| qyuns.net | 2015 | Taizhou, China | $66.35M | – | Drug development services are provided to the biopharma sector. | |
| conceptlifesciences.com | 2014 | Manchester, United Kingdom | – | – | International laboratory testing and consultancy in life sciences are offered. | |
| staqpharma.com | 2018 | Denver, United States | $33.52M | 30 | Drug discovery services are provided for pharmaceutical innovation. |
Detailed competitors of R2M Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of R2M Pharma
The website of R2M Pharma (r2mpharma.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▼ 6.8% vs previous month
Websites whose visitors overlap most with R2M Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ossiumhealth.com | 100% | 7.5K | #3,051,166 | View details | |
| circlepharma.com | 100% | 2.8K | #6,088,315 | View details | |
| neuronatherapeutics.com | 100% | 9.4K | – | View details | |
| quantatx.com | 100% | 3.1K | #5,909,422 | View details | |
| siteonetherapeutics.com | 100% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 28 similar websites and full traffic analytics for R2M Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 28 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as R2M Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about R2M Pharma
R2M Pharma was founded in 2017.
R2M Pharma is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Julio Medina is the current CEO of R2M Pharma. They have also founded this company.
R2M Pharma has 1 employees.
R2M Pharma specializes in accelerating drug discovery by providing expert services such as target validation, compound optimization, DMPK, and patent strategy to start-up biotech companies. They operate as a professional resource for firms lacking internal expertise, collaborating efficiently on small molecule development. Based in South San Francisco, USA, they have worked with clients like Tenaya Therapeutics to enhance drug programs.
R2M Pharma's top competitors include Evotec, Crown Bioscience and NIH.
R2M Pharma offers Target Validation Services, Compound Optimization, DMPK Services, and Patent Strategy.
R2M Pharma operates through R2m.